Golden Meditech Announces 2012 / 2013 Interim Results
11/27/2012 9:34:08 AM
Golden Meditech Holdings Limited ("Golden Meditech," together with its subsidiaries collectively as the "Group," - 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, is pleased to announce the Group's interim results for the six months ended 30 September 2012.
During the interim period, the Group reported financial results that were in line with management expectations and barely affected by the current global environment. Total revenue for the interim period increased by 6.4% to HK$224,464,000. Profit attributable to shareholders of the period increased by 11.2% to HK$85,255,000. Excluding non-cash gain of HK$54,892,000 due to fair value changes of financial assets and financial liabilities, adjusted profit attributable to shareholders of the period, which included contributions from associates, dropped by 63.6% to HK$30,363,000.